LBA81 Durvalumab (D) as consolidation therapy in limited-stage SCLC (LS-SCLC): Outcomes by prior concurrent chemoradiotherapy (cCRT) regimen and prophylactic cranial irradiation (PCI) use in the ADRIATIC trial - Concepedia

Concepedia

Publication | Open Access

LBA81 Durvalumab (D) as consolidation therapy in limited-stage SCLC (LS-SCLC): Outcomes by prior concurrent chemoradiotherapy (cCRT) regimen and prophylactic cranial irradiation (PCI) use in the ADRIATIC trial

DOI Full Paper Access

11

Citations

0

References

2024

Year

S. Senan, David R. Spigel, Byoung Chul Cho, Yoshitaka Zenke, Ki Hyeong Lee, Q. Wang, A.F. Navarro Mendivil, E.L. Buchmeier, Sema Sezgin Göksu, A. Badzio,

Annals of Oncology

No additional data available for this publication yet. Check back later!